E von Willebrand
Overview
Explore the profile of E von Willebrand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olkinuora H, Willebrand E, Kantele J, Vainio O, Talvensaari K, Saarinen-Pihkala U, et al.
Scand J Immunol
. 2011 Feb;
73(6):586-93.
PMID: 21323694
Viral infections and graft-versus-host disease (GVHD) render an impact on both the clinical and immunological recovery following allogeneic hematopoietic stem cell transplantation (HSCT). We studied the recuperation of the immune...
2.
Rintala J, Savikko J, Rintala S, Willebrand E
Transplant Proc
. 2006 Dec;
38(10):3239-40.
PMID: 17175234
Background: Chronic allograft nephropathy (CAN) remains the primary reason for late allograft loss in kidney transplantation. Transforming growth factor beta (TGF-beta) is a major mitogen mediating mesenchymal cell proliferation and...
3.
Rintala S, Savikko J, Rintala J, Willebrand E
Transplant Proc
. 2006 Dec;
38(10):3236-8.
PMID: 17175233
Background: Acute rejection is the single most important risk factor for the subsequent development of chronic allograft nephropathy (CAN), which is still the primary reason for late allograft loss in...
4.
Rintala J, Savikko J, Rintala S, Willebrand E
Transplant Proc
. 2006 Nov;
38(8):2719-21.
PMID: 17098049
Background: Acute rejection is the single most important risk factor for the development of subsequent chronic allograft nephropathy (CAN). Both platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta) are...
5.
Savikko J, Willebrand E
Transplant Proc
. 2006 Nov;
38(8):2699-700.
PMID: 17098043
Chronic allograft nephropathy (CAN) is the primary reason for late allograft loss in kidney transplantation. The use of calcineurin inhibitors is suggested to be a risk factor for the development...
6.
Turpeinen A, Willebrand E, Salminen I, Linden J, Basu S, Rai D
Lipids
. 2006 Oct;
41(7):669-77.
PMID: 17069351
CLA intake in exclusively breast-fed infants is close to levels found to have physiological effects in animals. However, in the majority of studies mixtures of CLA isomers have been used...
7.
Willebrand E, Savikko J, Merenmies J, Jalanko H
Transplant Proc
. 2005 Apr;
37(2):945-6.
PMID: 15848583
We wanted to develop an immunostaining method of urine cytopreparations to detect polyoma virus infection by using fresh urine samples and staining with the monoclonal SV40 antibody and to compare...
8.
Savikko J, Taskinen E, Willebrand E
Transplant Proc
. 2002 Aug;
34(5):1382.
PMID: 12176405
No abstract available.
9.
Savikko J, Kallio E, Willebrand E
Transplantation
. 2001 Jul;
72(1):31-7.
PMID: 11468531
Background: Acute rejection is the single most important risk factor for the development of subsequent chronic rejection. Platelet-derived growth factor (PDGF) is a major mitogen that mediates mesenchymal cell proliferation...
10.
Savikko J, Kallio E, Willebrand E
Transplant Proc
. 2001 Jun;
33(4):2479-80.
PMID: 11406219
No abstract available.